Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating psilocybin-assisted therapy for people with comorbid major depressive disorder and alcohol use disorder; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) | Phase 2 | Status: NOT_YET_RECRUITING